↓ Skip to main content

Development and dosimetry of 203Pb/212Pb-labelled PSMA ligands: bringing “the lead” into PSMA-targeted alpha therapy?

Overview of attention for article published in European Journal of Nuclear Medicine and Molecular Imaging, January 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

twitter
2 X users
patent
11 patents

Citations

dimensions_citation
78 Dimensions

Readers on

mendeley
72 Mendeley
Title
Development and dosimetry of 203Pb/212Pb-labelled PSMA ligands: bringing “the lead” into PSMA-targeted alpha therapy?
Published in
European Journal of Nuclear Medicine and Molecular Imaging, January 2019
DOI 10.1007/s00259-018-4220-z
Pubmed ID
Authors

José Carlos dos Santos, Martin Schäfer, Ulrike Bauder-Wüst, Wencke Lehnert, Karin Leotta, Alfred Morgenstern, Klaus Kopka, Uwe Haberkorn, Walter Mier, Clemens Kratochwil

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 72 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 72 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 13 18%
Student > Master 8 11%
Researcher 8 11%
Student > Bachelor 7 10%
Other 5 7%
Other 6 8%
Unknown 25 35%
Readers by discipline Count As %
Chemistry 18 25%
Medicine and Dentistry 9 13%
Physics and Astronomy 8 11%
Engineering 3 4%
Agricultural and Biological Sciences 2 3%
Other 7 10%
Unknown 25 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 March 2024.
All research outputs
#2,597,378
of 25,008,338 outputs
Outputs from European Journal of Nuclear Medicine and Molecular Imaging
#198
of 3,459 outputs
Outputs of similar age
#58,231
of 449,195 outputs
Outputs of similar age from European Journal of Nuclear Medicine and Molecular Imaging
#4
of 45 outputs
Altmetric has tracked 25,008,338 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,459 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.4. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 449,195 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 45 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.